Cadinane-type sesquiterpenes from the resinous exudates of Commiphora myrrha and their anti-Alzheimer's disease bioactivities. - GreenMedInfo Summary

n/a

Abstract Title:

Cadinane-type sesquiterpenes from the resinous exudates of Commiphora myrrha and their anti-Alzheimer's disease bioactivities.

Abstract Source:

Fitoterapia. 2020 Apr ;142:104536. Epub 2020 Mar 5. PMID: 32145310

Abstract Author(s):

Yi-Fan Yu, Ying-Hong Liu, Xiao-Han Chen, De-Juan Zhi, Feng-Ming Qi, Zong-Ping Zhang, Yue-Qian Li, Zhan-Xin Zhang, Dong-Qing Fei

Article Affiliation:

Yi-Fan Yu

Abstract:

Commiphoins A-C (1-3), three new cadinane-type sesquiterpenes, together with two known cadinane-type sesquiterpenes (4 and 5) were isolated from the resinous exudates of Commiphora myrrha. Their structures and relative configurations were established on the basis of comprehensive spectroscopic methods, including HRESIMS, 1D and 2D NMR analyses. Compounds 1 and 3-5 were screened for anti-Alzheimer's disease (AD) activities using the AD pathological model in Caenorhabditis elegans. The results showed that they all had significant anti-AD activities.

Article Published Date : Mar 31, 2020

Study Type : In Vitro Study

Additional Links

Substances : Myrrh : CK(85) : AC(41)

Diseases : Alzheimer's Disease : CK(3372) : AC(1307)

Pharmacological Actions : Neuroprotective Agents : CK(10404) : AC(4396)

Print Options

Some features are currently member only features. If you are already a member, please login. Otherwise, click here to become a member.

Printer-friendly version

Cadinane-type sesquiterpenes from the resinous exudates of Commiphora myrrha and their anti-Alzheimer's disease bioactivities. - GreenMedInfo Summary

Print Options

Key Research Topics

Subscribe to our informative Newsletter & get Nature's Evidence-Based Pharmacy

Our newsletter serves 500,000 with essential news, research & healthy tips, daily.